Clinical Significance of Quantitative Analysis of Plasma Epstein-Barr Virus DNA in Patients of Xinjiang Uygur Nationality with Hodgkin's Lymphoma |
Li, Xun
(Department of Medical Oncology, Affiliated Tumor Hospital, Xinjiang Medical University)
Yang, Shun-E. (Department of Medical Oncology, Affiliated Tumor Hospital, Xinjiang Medical University) Guo, Yun-Quan (Department of Medical Oncology, Affiliated Tumor Hospital, Xinjiang Medical University) Shen, Ming-Xia (Department of Medical Oncology, Affiliated Tumor Hospital, Xinjiang Medical University) Gu, Li (Department of Medical Oncology, Affiliated Tumor Hospital, Xinjiang Medical University) Gulikezi, Gulikezi (Department of Medical Oncology, Affiliated Tumor Hospital, Xinjiang Medical University) Zhao, Bing (Department of Medical Oncology, Affiliated Tumor Hospital, Xinjiang Medical University) Liu, Wei (Department of Medical Oncology, Affiliated Tumor Hospital, Xinjiang Medical University) Tuerxun, Tuerxun (Department of Medical Oncology, Affiliated Tumor Hospital, Xinjiang Medical University) Bai, Jing-Ping (Department of Medical Oncology, Affiliated Tumor Hospital, Xinjiang Medical University) |
1 | Massini G, Siemer D, Hohaus S (2009). EBV in hodgkin lymphoma. Mediterr J Hematol Infect Dis, 1, e2009013. |
2 | Musacchio JG, Carvelho Mda G, Morais JC, et al (2006). Detection of free circulating Epstein-Barr virus DNA in plasma of patients with Hodgkin's disease. Sao Paulo Med J, 124, 154-7. |
3 | Pajand O, Pourakbari B, Mahjob F, et al (2011). Detection of Epstein-Barr virus DNA in plasma and lymph node biopsy samples of pediatric and adult patients with Hodgkin lymphoma. Pediatr Hematol Oncol, 28, 10-5. DOI ScienceOn |
4 | Spacek M, Hubacek P, Markova J, et al (2011). Plasma EBVDNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patients. APMIS, 119, 10-6. |
5 | Umetani N, Hiramatsu S, Hoon DS (2006). Higher amount of free circulating DNA in serum than in plasma is not mainly caused by contaminated extraneous DNA during separation. Ann N Y Acad Sci, 1075, 299-307. DOI ScienceOn |
6 | Wagner HJ, Schlager F, Claviez A, Bucsky P (2001). Detection of Epstein-Barr virus DNA in peripheral blood of paediatric patients with Hodgkin's disease by real-time polymerase chain reaction. Eur J Cancer, 37, 1853-7. DOI ScienceOn |
7 | Wagner HJ, Wessel M, Jabs W, et al (2001). Patients at risk for development of posttransplant lymphoproliferative disorder: plasma versus peripheral blood mononuclear cells as material for quantification of Epstein-Barr viral load by using real-time quantitative polymerase chain reaction. Transplantation, 72, 1012-9. DOI ScienceOn |
8 | Zhou XG, Sandvej K, Li PJ, et al (2001). Epstein-Barr virus (EBV) in Chinese pediatric Hodgkin disease: Hodgkin disease in young children is an EBV-related lymphoma. Cancer, 92, 1621-31. DOI ScienceOn |
9 | Anker P, Mulcahy H, Chen XQ, Stroun M (1999). Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients. Cancer Metastasis Rev, 18, 65-73. DOI ScienceOn |
10 | Chabay PA, Barros MH, Hassan R, et al (2008). Pediatric Hodgkin lymphoma in 2 South American series: a distinctive epidemiologic pattern and lack of association of Epstein-Barr virus with clinical outcome. J Pediatr Hematol Oncol, 30, 285-91. DOI ScienceOn |
11 | Chan A, Zhung J, Chan A, et al (2003). Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients. Cancer Res, 63, 2028-32. |
12 | Dinand V, Arya LS (2006). Epidemiology of childhood hodgkins disease: is it different in developing countries? Indian Pediatr, 43, 141-7. |
13 | Hohaus S, Santangelo R, Giachelia M, et al (2011). The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma. Clin Cancer Res, 17, 2885-92. DOI |
14 | Gallagher A, Armstrong AA, MacKenzie J, et al (1999). Detection of Epstein-Barr virus (EBV) genomes in the serum of patients with EBV-associated Hodgkin's disease. Int J Cancer, 84, 442-8. DOI ScienceOn |
15 | Gandhi MK, Lambley E, Burrows J, et al (2006). Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma. Clin Cancer Res, 12, 460-4. DOI ScienceOn |
16 | Halliday C, Wu QX, James G, Sorrell T (2005).Development of a nested qualitative real-time PCR assay to detect Aspergillus species DNA in clinical specimens. J Clin Microbiol, 43, 5366-8. DOI ScienceOn |
17 | Huang X, Hepkema B, Nolte I, et al (2012). HLA-A*02:07 is a protective allele for EBV negative and a susceptibility allele for EBV positive classical Hodgkin lymphoma in China. PLoS One, 7, e31865. DOI |
18 | Huang X, Nolte I, Gao Z, et al (2011). Epidemiology of classical hodgkin lymphoma and its association with epstein barr virus in northern China. PLoS One, 6, e21152. DOI |
19 | Ishii H, Ogino T, Berger C, et al (2007). Clinical usefulness of serum EBV DNA levels of BamHI W and LMP1 for Nasal NK/T-cell lymphoma. J Med Virol, 79, 562-72. DOI ScienceOn |
20 | Jarrett RF (2003). Risk factors for Hodgkin's lymphoma by EBV status and significance of detection of EBV genomes in serum of patients with EBV-associated Hodgkin's lymphoma. Leuk Lymphoma, 44, S27-32. DOI ScienceOn |
21 | Le QT, Jones CD, Yau TK, et al (2005). A comparison study of different PCR assays in measuring circulating plasma epstein-barr virus DNA levels in patients with nasopharyngeal carcinoma. Clin Cancer Res, 11, 5700-7. DOI ScienceOn |
22 | Lo YM, Chan LY, Lo KW, et al (1999). Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res, 59, 1188-91. |